Resistell AG: Clinical Trials

2 trials sponsored by Resistell AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. .

Follow Resistell AG: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
Resistell Phenotech - Bacteremia Sepsis
TerminatedResistell AG2462023-01-182024-10-26
Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
Resistell AST - Bacteremia Sepsis
CompletedResistell AG3002021-06-182024-04-10

Conditions studied

Disease Susceptibility (1)  ·  Escherichia coli Infections (1)

Countries

Switzerland (2)  ·  Austria (1)  ·  Spain (1)

Results publications

PMID 36410804, PMID 38499536, PMID 41173335